Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5191946
Max Phase: Preclinical
Molecular Formula: C28H36ClN3O2
Molecular Weight: 482.07
Associated Items:
ID: ALA5191946
Max Phase: Preclinical
Molecular Formula: C28H36ClN3O2
Molecular Weight: 482.07
Associated Items:
Canonical SMILES: CCN(C(=O)CC(CC(=O)NCCN1CCCC1)c1ccc(Cl)cc1)C1Cc2ccccc2C1
Standard InChI: InChI=1S/C28H36ClN3O2/c1-2-32(26-17-22-7-3-4-8-23(22)18-26)28(34)20-24(21-9-11-25(29)12-10-21)19-27(33)30-13-16-31-14-5-6-15-31/h3-4,7-12,24,26H,2,5-6,13-20H2,1H3,(H,30,33)
Standard InChI Key: KZLCDCIVPHFRJV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 482.07 | Molecular Weight (Monoisotopic): 481.2496 | AlogP: 4.43 | #Rotatable Bonds: 10 |
Polar Surface Area: 52.65 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.56 | CX LogP: 4.02 | CX LogD: 2.84 |
Aromatic Rings: 2 | Heavy Atoms: 34 | QED Weighted: 0.55 | Np Likeness Score: -1.23 |
1. Lv YB, Chen C, Yu QM, Lyu L, Peng YF, Tan XD.. (2022) Synthesis and biological evaluation of novel pentanediamide derivatives as S-adenosyl-l-homocysteine hydrolase inhibitors., 72 [PMID:35809817] [10.1016/j.bmcl.2022.128880] |
Source(1):